DK368486A - Steroider der er virksomme mod cancer, obesitet, hyperglycaemi, autoimmunreaktion og hypercholesterolaemi - Google Patents

Steroider der er virksomme mod cancer, obesitet, hyperglycaemi, autoimmunreaktion og hypercholesterolaemi Download PDF

Info

Publication number
DK368486A
DK368486A DK368486A DK368486A DK368486A DK 368486 A DK368486 A DK 368486A DK 368486 A DK368486 A DK 368486A DK 368486 A DK368486 A DK 368486A DK 368486 A DK368486 A DK 368486A
Authority
DK
Denmark
Prior art keywords
obesidence
hypercholesterolaemia
hyperglycaemia
steroids
immune reaction
Prior art date
Application number
DK368486A
Other languages
English (en)
Other versions
DK171968B1 (da
DK368486D0 (da
Inventor
Arthur G Schwartz
Marvin Louis Lewbart
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of DK368486D0 publication Critical patent/DK368486D0/da
Publication of DK368486A publication Critical patent/DK368486A/da
Application granted granted Critical
Publication of DK171968B1 publication Critical patent/DK171968B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J11/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/008Ketals at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016Oximes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK368486A 1985-08-02 1986-08-01 5-androsten-17-on-forbindelser samt terapeutisk præparat, der indeholder en sådan forbindelse DK171968B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76258485A 1985-08-02 1985-08-02
US76258485 1985-08-02

Publications (3)

Publication Number Publication Date
DK368486D0 DK368486D0 (da) 1986-08-01
DK368486A true DK368486A (da) 1987-02-03
DK171968B1 DK171968B1 (da) 1997-09-01

Family

ID=25065487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK368486A DK171968B1 (da) 1985-08-02 1986-08-01 5-androsten-17-on-forbindelser samt terapeutisk præparat, der indeholder en sådan forbindelse

Country Status (11)

Country Link
EP (1) EP0210665B1 (da)
JP (1) JP2512439B2 (da)
AU (1) AU598201B2 (da)
CA (1) CA1314871C (da)
DE (1) DE3666437D1 (da)
DK (1) DK171968B1 (da)
ES (1) ES2000613A6 (da)
GR (1) GR862043B (da)
IE (1) IE58540B1 (da)
IL (1) IL79583A (da)
PT (1) PT83138B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60027B1 (en) * 1986-05-21 1994-05-18 Research Corp Steroids useful as anti-cancer and anti-obesity agents
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5424463A (en) * 1990-08-29 1995-06-13 Humanetics Corporation Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process
US5585371A (en) * 1990-08-29 1996-12-17 Humanetics Corporation Treatment of immune system with Δ5-androstenes
JP3029907B2 (ja) * 1991-12-20 2000-04-10 理化学研究所 抗肥満剤
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
EP0907351B2 (de) * 1996-03-29 2012-04-18 Keyvest GmbH Kosmetikum bzw. kosmetikzusammensetzung zur glättung und straffung der haut bei gestörtem unterhaut-binde-fettgewebe, insbesondere bei der "cellulite"
CN103409144B (zh) * 2013-08-16 2014-11-26 东北大学 含甾体基元的环状碳酸酯类活泼液晶单体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS598074B2 (ja) * 1979-01-23 1984-02-22 沖電気工業株式会社 発光素子アレイ装置
JPS59155140U (ja) * 1983-04-06 1984-10-18 沖電気工業株式会社 光プリントヘツドの組立構造
JPS6069096A (ja) * 1983-08-02 1985-04-19 リサ−チ・コ−ポレイシヨン 新規ステロイド
JPS6162016A (ja) * 1984-09-03 1986-03-29 Nhk Spring Co Ltd Ledプリンタヘツド

Also Published As

Publication number Publication date
CA1314871C (en) 1993-03-23
GR862043B (en) 1986-12-24
IE862062L (en) 1987-02-02
PT83138B (pt) 1989-03-30
AU598201B2 (en) 1990-06-21
ES2000613A6 (es) 1988-03-01
DK171968B1 (da) 1997-09-01
JP2512439B2 (ja) 1996-07-03
AU6079786A (en) 1987-02-05
JPS6248693A (ja) 1987-03-03
EP0210665A1 (en) 1987-02-04
PT83138A (en) 1986-09-01
DE3666437D1 (en) 1989-11-23
IE58540B1 (en) 1993-10-06
DK368486D0 (da) 1986-08-01
EP0210665B1 (en) 1989-10-18
IL79583A (en) 1990-11-29
IL79583A0 (en) 1986-11-30

Similar Documents

Publication Publication Date Title
DE3880644T2 (de) Feuchtigkeitsvernetzbare Polyisobutylene.
EP0247071A4 (en) IMMUNOTHERAPEUTIC TREATMENT.
DE3686463D1 (de) Empfaengnisverhuetendes mittel.
GB2172660B (en) Hydraulic noise attenuators
DK665187D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling heraf
FI94003B (fi) Laajentuva nauha kaapeleita varten, sen käyttö ja kaapelit
DK368486D0 (da) Steroider der er virksomme mod cancer, obesitet, hyperglycaemi, autoimmunreaktion og hypercholesterolaemi
DK82686D0 (da) (1-benzyl-ethylendiamin)-platin(ii)-komplekser og fremgangsmaade til fremstilling heraf
HUT41929A (en) Wide-band, space-split signal-switching apparatus
NO884132L (no) Aluminiumoksyd-baserte katalysatorer og fremgangsmaate forderes fremstilling.
TR23713A (tr) Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
DK151788D0 (da) Hybridserpiner og dna, som koder derfor
GB8610363D0 (en) Electroelution device
DK396786D0 (da) Gem-dihalogen- og tetrahalogen-1,12-diamino-4,9-diazadedecaner, deresfremstilling og anvendelse
DK160087A (da) Katalysatorkomponent og fremgangsmaade til fremstilling deraf
GB2172163B (en) Attenuator apparatus
GB2175764B (en) Attenuator
NO870835L (no) Anordning for forming og pressing av ystel.
NO162724C (no) Fremgangsmaate til fremstilling av en polymerisasjonskatalysator og anvendelse av katalysatoren.
GB2189959B (en) Attenuator apparatus
AU556222B3 (en) Biorhythms calculating device employing concentric bands marked with incidicia
GB8611693D0 (en) Stapling device
GB8515054D0 (en) Self-tensioning device
NO872468L (no) Dihydrobenzotiofen og tiokromanaminoalkoholer.
GB8525407D0 (en) Attenuator apparatus

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK